Amerisource Health Services is recalling approximately 93,600 tablets of Enalapril Maleate (5 mg), a prescription medication used to treat high blood pressure. This recall was initiated because the tablets failed stability specifications, meaning the drug may not maintain its required strength or quality through its expiration date. Using a medication that has lost its potency can lead to ineffective treatment of blood pressure conditions. The affected products were distributed nationwide in the USA and Puerto Rico.
The tablets failed to meet stability standards, which can result in the medication losing its effectiveness before the labeled expiration date. For patients relying on this drug to manage hypertension, reduced potency could lead to uncontrolled high blood pressure and related health complications.
Pharmacy refund and healthcare consultation
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.